Sherrill B, Sherif B, Amonkar MM, Maltzman J, O'Rourke L, Johnston S. Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib. Curr Med Res Opin. 2011 Dec 1;27(12):2245-52.
Morton JM, DeMaria E, Winegar D, Sherif BN, Hutcher N, Blackstone R. Is ambulatory laparoscopic roux en y gastric bypass from the bariatric outcomes longitudinal database (BOLD) associated with higher adverse events? Presented at the 28th Annual Meeting of the American Society for Metabolic and Bariatric Surgery; June 12, 2011.
Winegar DA, DeMaria EJ, Sherif BN, Apovian CM. Indications for bariatric surgery in the bmi<35 kg/m2 population treated at ASMBS bariatric surgery centers of excellence (BSCOE'S) as reported in the bariatric outcomes longitudinal database (BOLD). Poster presented at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes; March 28, 2011.
Winegar DA, Sherif BN, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence participants: analysis of the bariatric outcomes longitudinal database. Surg Obes Relat Dis. 2011 Mar;7(2):181-8.